Departamento de Dermatología, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Servicio de Dermatología, Hospital Clínic de Barcelona, Universitat de Barcelona, España.
Actas Dermosifiliogr (Engl Ed). 2020 Sep;111(7):545-560. doi: 10.1016/j.ad.2020.03.005. Epub 2020 May 13.
Porokeratosis comprises a group of heterogeneous and uncommon acquired or congenital skin diseases of unknown origin characterized by a keratinization disorder resulting from abnormal clonal expansion of keratinocytes. Numerous genetic mutations are thought to be involved. These conditions are characterized histologically by the presence of a cornoid lamella. Clinical manifestations are variable, with localized, disseminated, and even eruptive forms. Porokeratosis has been associated with immunosuppression, ultraviolet radiation, and systemic, infectious, and neoplastic diseases. Many authors consider it to be a premalignant condition because of the potential for malignant transformation to squamous cell or basal cell carcinoma. Therefore, long-term follow-up is a key component of treatment, which is usually complex and often unsatisfactory. We review the latest advances in our understanding of the pathogenesis, diagnosis, and treatment and propose a treatment algorithm.
棘层松解角化不良症包括一组异质性和罕见的获得性或先天性皮肤疾病,其病因不明,特征为角化细胞异常克隆性扩张导致的角化障碍。据认为,这些情况与众多遗传突变有关。这些疾病在组织学上的特征是存在 Cornoid 板层。临床表现多种多样,包括局限性、播散性甚至暴发性形式。棘层松解角化不良症与免疫抑制、紫外线辐射以及系统性、感染性和肿瘤性疾病有关。许多作者认为它是一种癌前状态,因为有向鳞状细胞或基底细胞癌恶性转化的可能。因此,长期随访是治疗的关键组成部分,治疗通常较为复杂,且往往不尽如人意。我们回顾了对发病机制、诊断和治疗的最新认识,并提出了治疗算法。